| Literature DB >> 3818144 |
K Sertl, S Meryn, W Graninger, A Laggner, W Schlick, H Rameis.
Abstract
The response to pirenzepin, a new acetylcholine receptor blocking agent, was assessed and compared to placebo in patients with reversible bronchoconstriction. A single intravenous injection of 20 mg of pirenzepin induced a significant reduction of airway resistance compared to placebo (p less than 0.05). The anticholinergic substance pirenzepin appears to be useful in the treatment of bronchospasm.Entities:
Mesh：
Substances：
Year: 1986 PMID： 3818144
Source DB: PubMed Journal: Int J Clin Pharmacol Ther Toxicol ISSN： 0174-4879